UltraTech Cement Share Price Target 2026, 2027, 2028, 2029, 2030

UltraTech Cement share price today

UltraTech Cement Ltd (NSE: ULTRACEMCO) is a cement business with a market capitalisation of ₹3,59,213 Cr in Gale’s internal 6 August 2026 research snapshot. The stock was recorded at ₹12,105, against a 52-week range of ₹10,362 to ₹13,052. The live box above updates independently; every fundamental ratio below stays tied to the dated snapshot so market movement is never confused with a refreshed financial statement.

The central case is scale leadership in a cyclical consolidation story. India’s largest cement producer benefits from scale, distribution, low-cost capacity and the consolidation of a fragmented industry. The internal figures show 12.7% ROCE, 11.1% ROE and 8.1% five-year profit growth. Those are attractive headline numbers, but the stock market pays for what comes next. This article therefore separates business quality, current momentum and valuation instead of treating them as one idea.

What the business actually earns money from

UltraTech is India’s largest cement producer, with integrated plants, grinding units, logistics and distribution across regions. Scale helps with fuel sourcing, freight optimisation, brand reach and the ability to move volume between markets. Consolidation can improve industry structure, although every acquired tonne must still earn an acceptable return.

The durable advantage is national scale, logistics reach and purchasing power in a consolidating cement market. A moat should show up in numbers, not adjectives. Here the tests are return on capital, margin resilience, market-share behaviour and the amount of balance-sheet funding needed to grow. The snapshot’s 13.1% five-year average ROCE is more informative than a single strong year because it spans changes in demand and input costs.

Cement leadership does not remove cement cyclicality. Regional oversupply can weaken prices even when national demand looks healthy, while fuel and freight can change faster than selling prices. UltraTech’s advantage is the ability to optimise a broad network; the risk is deploying ever more capital for returns that remain near the industry’s cost of capital.

The investment debate

Cement demand benefits from housing and infrastructure, but the product remains cyclical and local. A national growth narrative can be overwhelmed by regional prices, pet-coke costs and capacity additions. The company deserves a leadership premium; the difficult question is how much premium remains justified when five-year ROCE is only 13.1% in a capital-intensive business.

The historical growth split helps frame that debate. Sales compounded at 14.6% and profit at 8.1% over five years. Over three years those rates were 11.9% and 17.5%. Profit growth has accelerated versus the five-year record. That is not automatically bullish or bearish: acceleration can reflect a sustainable mix shift or a low base, while deceleration can be temporary or the first evidence that the old multiple is no longer deserved.

The stock sat about 7.3% below its 52-week high and 16.8% above its low in the snapshot. Distance from a high is not valuation. It is useful only when paired with earnings, balance-sheet and competitive evidence.

Why more tonnes do not automatically mean more value

Cement capacity is easy to celebrate and expensive to earn a return on. A new integrated plant ties up capital before utilisation reaches an efficient level; a grinding unit still depends on clinker, logistics and a viable local market. UltraTech’s scale can lower procurement and distribution costs, but the relevant investor test is incremental ROCE: does each new or acquired tonne lift cash profit enough to cover the cost of capital? Volume growth accompanied by falling realisation or chronically low utilisation can expand reported market share while diluting value per share.

That is why the base case does not simply extend the company’s historical capacity additions into an equally fast EPS line. It assumes a more measured earnings path in which commissioning costs, depreciation and interest absorb part of the operating gain. The bull case needs both utilisation and pricing discipline; the bear case captures the possibility that industry supply arrives before demand.

EBITDA per tonne is the operating scoreboard

Revenue growth mixes volume, geography and price, so it can conceal weakening unit economics. For a cement producer, EBITDA per tonne and cash cost per tonne are more revealing. Fuel and power, limestone availability, railway or road freight, lead distance and regional selling prices can move in different directions. A national footprint provides optimisation choices, but cement is still a heavy, low-value-to-weight product whose economics are local.

Investors should therefore compare quarterly volume growth with realisation and variable cost, not read any one number alone. A cost saving caused by temporarily cheap fuel deserves a lower valuation than a structural saving from renewable power, waste-heat recovery or better logistics. Similarly, premium-product mix helps only if it survives competitive discounting. Sustained EBITDA-per-tonne improvement would support the higher scenario; erosion despite strong demand would challenge the leadership premium.

Consolidation has to pass a cash-return test

Acquisitions can add scarce limestone reserves, distribution and faster regional entry. They can also transfer an optimistic seller’s price onto the buyer’s balance sheet. The acquisition test is not whether reported capacity rises, but whether the purchased assets reach targeted utilisation without excessive refurbishment, working capital or debt. UltraTech’s 0.31 debt-to-equity ratio offers room, yet every large deal competes with greenfield capex, dividends and balance-sheet resilience.

The cleanest evidence will be post-acquisition cash generation and group ROCE. If net debt climbs while consolidated returns stagnate, the strategic narrative is not creating enough shareholder value. If integration lifts utilisation, logistics density and cash profit while leverage normalises, consolidation becomes a genuine advantage rather than a size statistic.

Growth, margins and capital efficiency

Operating evidence	6 Aug 2026 snapshot	How to read it
Sales CAGR, 5 years	14.6%	Demand, pricing and consolidation together
Profit CAGR, 5 years	8.1%	Includes margin and financial leverage
Sales CAGR, 3 years	11.9%	More recent top-line momentum
Profit CAGR, 3 years	17.5%	More recent earnings momentum
Operating margin	19.2%	Business-model economics before interest and tax
ROCE / five-year ROCE	12.7% / 13.1%	Current return versus durability
ROE	11.1%	Return delivered on shareholder equity

UltraTech’s 19.2% operating margin sits before depreciation and financing on a large asset base. It should be read with utilisation, EBITDA per tonne and ROCE rather than compared mechanically with an asset-light company. The desirable pattern is higher volume plus resilient unit profit and improving returns as new kilns mature. Capacity growth with falling ROCE would signal that scale is being purchased too aggressively.

The three-year profit CAGR exceeds the five-year rate even though recent sales growth is slower. That suggests margin recovery has contributed more than pure volume. Our base case therefore stays below the recent profit pace: cement margins mean-revert, and a normalised model should not turn one favourable fuel-and-price phase into a permanent slope.

Balance sheet, ownership and cash-flow questions

Debt to equity of 0.31 is manageable, but expansion should still be judged against operating cash flow. Promoter holding is 59.33%. The snapshot records zero promoter pledge, removing one common governance risk, though it does not replace scrutiny of related-party transactions and capital allocation.

Balance-sheet and ownership check	Snapshot
Debt to equity	0.31
Promoter holding	59.33%
Promoter pledge	0.00%
Book value per share	₹2,599.15
Dividend yield	1.97%

For UltraTech, the cash-flow bridge is dominated by maintenance capex, new capacity, acquisitions and debt service rather than receivables alone. Compare operating cash flow with profit over a full cement cycle, then deduct the capital needed merely to keep plants efficient and compliant. Free cash flow that stays weak after commissioning would undermine the argument that scale is compounding shareholder value.

Dividend yield of 1.97% is not the main reason to own the stock; most of the expected return must come from earnings growth and valuation discipline. The payout should be viewed after necessary reinvestment, not in isolation.

The numbers

Metric	Internal research snapshot
Market capitalisation	₹3,59,213 Cr
Snapshot price	₹12,105
P/E · price/book	41.7 · 4.69
PEG · EV/EBITDA	5.13 · 21.0
ROE · ROCE	11.1% · 12.7%
Operating margin	19.2%
Debt/equity	0.31
EPS (TTM)	₹292.68
Book value per share	₹2,599.15
52-week range	₹10,362 – ₹13,052

Valuation: what today’s multiple already assumes

The snapshot P/E is 41.7 times, price/book 4.69 times, PEG 5.13, and EV/EBITDA 21.0 times. No one ratio settles the case. P/E connects price to shareholder earnings; EV/EBITDA helps compare operations before financing; price/book matters when the asset base is economically meaningful; PEG is only as reliable as the growth rate placed beneath it.

Quality alone is not a buying signal. At the recorded valuation, execution must justify a substantial premium; a wider margin of safety matters more than a confident story. The target framework compounds the recorded TTM EPS of ₹292.68 and applies different exit multiples. It does not assume that today’s multiple survives automatically. That distinction matters because a company can grow profit while its share price disappoints if the starting valuation was too optimistic.

Scenario	EPS growth assumption	Exit P/E	What must be true
Bear	5%	24×	Competitive or cyclical pressure slows growth and the premium contracts
Base	10%	32×	The core franchise executes without assuming a perfect cycle
Bull	15%	41×	Growth stays strong and the market continues to pay for quality

UltraTech Cement share price target 2026 to 2030

The bear, base and bull paths use the assumptions above for every year through 2030. They are scenario arithmetic, not a forecast of where the share must trade. The model uses one consistent diluted EPS base and rounds only the displayed outcomes. Dividends are not added to the price targets, so total shareholder return would differ from the table.

Scenario warning: earnings, capital structure and market multiples can all move outside these assumptions. Read the range as a sensitivity map, never as a promise or personalised recommendation.

The table is intentionally gated to a free signed-in account. That keeps the assumptions and target grid together, prevents a single number from being lifted out of context, and lets Gale show the member-only accumulation range separately from the public research.

What would change our mind

The thesis should be reviewed against measurable evidence, not daily price movement:

• Domestic volume growth and regional price realisation. A sustained adverse trend matters more than one noisy quarter.
• EBITDA per tonne after fuel and freight costs. A sustained adverse trend matters more than one noisy quarter.
• Net debt and return from acquired capacity. A sustained adverse trend matters more than one noisy quarter.
• Capacity utilisation versus industry additions. A sustained adverse trend matters more than one noisy quarter.

We would also revisit the model if equity dilution, a large acquisition or a material accounting change altered EPS comparability. Targets are not “set and forget”; the framework must be rebuilt when the business base changes.

Should you buy at the current price?

UltraTech Cement is a business to admire without automatically chasing the share. At this valuation, patience is an active decision: wait for either earnings to catch up or price to create a genuine margin of safety.

The signed-in panel shows Gale’s current rating, while paid members can see the accumulation range. Neither replaces position sizing or personal suitability. An investor already heavily exposed to cement faces a different decision from someone building a diversified portfolio.

FAQ

What is the UltraTech Cement share price target for 2030?

Gale publishes bear, base and bull outcomes for 2026–2030 in the signed-in table on this page. Each number comes from the stated EPS growth and exit P/E assumptions; there is no single assured target.

Is UltraTech Cement overvalued?

At 41.7 times earnings and 21.0 times EV/EBITDA in the snapshot, the shares require continued earnings delivery. Valuation becomes attractive only when the return implied by conservative assumptions compensates for the business risks.

What is UltraTech Cement’s main advantage?

The core advantage is national scale, logistics reach and purchasing power in a consolidating cement market. The evidence to follow is whether that advantage continues to produce stable market share, margins and returns on capital.

What is the biggest risk to the target model?

Cement remains cyclical and capital-heavy; pricing, fuel cost, acquisitions and regional utilisation can overwhelm volume growth. A lower growth rate and a lower multiple can occur together, which is why the bear path changes both variables.

Does UltraTech Cement pay a dividend?

The internal snapshot records a 1.97% dividend yield. It is secondary to earnings growth, and future payouts remain subject to board decisions and cash needs.

When are UltraTech Cement’s next results?

Use Gale’s results calendar for the announced date and check the exchange filing before relying on an estimate.

Related research

• Larsen & Toubro share price target
• IRB Infrastructure share price target
• Welspun Corp share price target

Sources: Screener.in company financials, captured in Gale’s approved internal research snapshot on 6 August 2026; company results, annual reports and exchange filings linked from that page. Live market price is supplied separately by Yahoo Finance and is indicative.

---

This article is research and education, not personalised investment advice. We are not SEBI-registered advisers. Price targets are scenario arithmetic, not promises. Do your own research and consult a registered adviser before acting.